CAMP4 THERAPEUTICS CORPORATION
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.0% | +25.1% | +4.2% | -0.6% | +0.6% | -15.7% | -4.1% | -0.3% | -99.9% | +86.3% | +436.5% | |
| – | +8.9% | +16.9% | +3.5% | +0.5% | +3.1% | -16.4% | -6.6% | +6.9% | -35.9% | – | – | |
| – | +17.8% | +39.2% | +5.3% | -2.1% | -3.0% | -14.6% | -0.4% | -10.6% | -99.7% | +86.3% | +185.1% | |
| – | -0.3% | +11.1% | +17.1% | +7.4% | +6.4% | -12.3% | +10.2% | -13.6% | +65.3% | -4.4% | -1.6% | |
| – | +60.9% | +123.0% | -6.8% | -40.4% | +85.6% | -14.9% | +6.6% | -1.0% | -77.6% | +28.5% | +16.3% | |
| – | +19.9% | +89.7% | +0.7% | -16.0% | +33.2% | -21.3% | +7.1% | -0.8% | -60.9% | +2.9% | +0.3% | |
| – | +12.6% | -95.2% | +493.2% | +147.6% | -185.1% | – | – | – | – | – | – | |
| – | +10,448.6% | +30.3% | +3.9% | +62.7% | +20.1% | -71.0% | -10.8% | +20.6% | -25.5% | – | – | |
| – | -9.9% | -131.2% | – | -16.9% | -344.5% | – | – | – | – | – | – | |
| – | -44.9% | -124.0% | – | -112.5% | – | -97.3% | +93.8% | +5.9% | -145.6% | – | – | |
| – | +2.6% | -142.2% | – | +10.7% | -528.2% | – | – | – | – | – | – | |
| – | +11.5% | -35.4% | +26.9% | +50.1% | -67.7% | -44.4% | -131.2% | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.